Behavioral Health Crisis Response Improvements Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Behavioral Health Crisis Response Improvements Act This bill authorizes the Office of Community Oriented Policing Services within the Department of Justice to make grants to law enforcement agencies for behavioral health crisis response training.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2020 · fourth_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry, S413, HR1316, HR1038; Congressional consideration of COVID relief packages; CARES Act Provider Relief Fund
Client expense: Not reported · Firm income: $90,000
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2020 · third_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry, S413, HR1316, HR1038; Congressional consideration of COVID relief packages; CARES Act Provider Relief Fund
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Health Issues
Legislation and regulations affecting the long-term care pharmacy industry, including S413, HR1316, HR1038; Congressional consideration of COVID relief packages
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · first_quarter · Health Issues
Legislation and regulations affecting drug pricing and the long-term care pharmacy industry, S413, HR1316, HR1038
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Health Issues
Legislation and regulations affecting drug pricing and the long-term care pharmacy industry, S413, HR1316, HR1038
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · third_quarter · Health Issues
Legislation and regulations affecting drug pricing and the long-term care pharmacy industry, S413, HR1316, HR1038
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Health Issues
Legislation and regulations affecting drug pricing and the long-term care pharmacy industry, S413, HR1316, HR1038
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · first_quarter · Health Issues
Legislation and regulations affecting drug pricing and the long-term care pharmacy industry, S413, HR1316, HR1038
Client expense: Not reported · Firm income: $90,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE